- $125.12bn
- $135.58bn
- $20.50bn
- 96
- 17
- 91
- 77
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 26.47 | ||
PEG Ratio (f) | 1.51 | ||
EPS Growth (f) | 21.31% | ||
Dividend Yield (f) | 1.01% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 6.53 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 43.78 | ||
Price to Sales | 5.97 | ||
EV to EBITDA | 26.3 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 12.71% | ||
Return on Equity | 18.64% | ||
Operating Margin | 19.68% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 14,884 | 14,351 | 17,108 | 18,449 | 20,498 | 22,290.23 | 24,015.06 | 8.55% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -37.46 | -10.51 | +31.39 | +9.72 | +7.33 | +27.56 | +11.89 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. It operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. Stryker is also engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. It also offers Fortress, a modular wall system for hospitals and ambulatory surgery centers.
Directors
- Kevin Lobo CHM (56)
- Glenn Boehnlein CFO (59)
- Viju Menon CEX (53)
- M. Kathryn Fink CHO (51)
- William Berry CAO (55)
- Yin Becker VPR (57)
- Robert Fletcher VPR (50)
- Allan Golston LED (54)
- Mary Brainerd IND (67)
- Giovanni Caforio IND (56)
- Srikant Datar IND (68)
- Sherilyn McCoy IND (62)
- Andrew Silvernail IND (50)
- Lisa Skeete Tatum IND (53)
- Ronda Stryker IND (66)
- Rajeev Suri IND (53)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- February 20th, 1946
- Public Since
- March 17th, 1980
- No. of Shareholders
- 2,501
- No. of Employees
- 52,000
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- New York Stock Exchange
- Shares in Issue
- 380,949,778
- Address
- 2825 Airview Blvd, KALAMAZOO, 49002
- Web
- https://www.stryker.com/
- Phone
- +1 2693892600
- Auditors
- Ernst & Young LLP
Latest News for SYK
Upcoming Events for SYK
Stryker Corp Annual Shareholders Meeting
Stryker Corp Annual Shareholders Meeting
Q2 2024 Stryker Corp Earnings Release
Q3 2024 Stryker Corp Earnings Release
Similar to SYK
Abbott Laboratories
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Agiliti
New York Stock Exchange
Alcon AG
New York Stock Exchange
Artivion
New York Stock Exchange
FAQ
As of Today at 01:21 UTC, shares in Stryker are trading at $328.45. This share price information is delayed by 15 minutes.
Shares in Stryker last closed at $328.45 and the price had moved by +15.4% over the past 365 days. In terms of relative price strength the Stryker share price has underperformed the S&P500 Index by -6.92% over the past year.
The overall consensus recommendation for Stryker is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Stryker dividend yield is 0.94% based on the trailing twelve month period.
Last year, Stryker paid a total dividend of $3.10, and it currently has a trailing dividend yield of 0.94%. We do not have any data on when Stryker is to next pay dividends.
We do not have data on when Stryker is to next pay dividends. The historic dividend yield on Stryker shares is currently 0.94%.
To buy shares in Stryker you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $328.45, shares in Stryker had a market capitalisation of $125.12bn.
Here are the trading details for Stryker:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: SYK
Based on an overall assessment of its quality, value and momentum Stryker is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Stryker is $379.41. That is 15.52% above the last closing price of $328.45.
Analysts covering Stryker currently have a consensus Earnings Per Share (EPS) forecast of $11.92 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Stryker. Over the past six months, its share price has outperformed the S&P500 Index by +1.24%.
As of the last closing price of $328.45, shares in Stryker were trading +7.35% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Stryker PE ratio based on its reported earnings over the past 12 months is 26.47. The shares last closed at $328.45.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Stryker's management team is headed by:
- Kevin Lobo - CHM
- Glenn Boehnlein - CFO
- Viju Menon - CEX
- M. Kathryn Fink - CHO
- William Berry - CAO
- Yin Becker - VPR
- Robert Fletcher - VPR
- Allan Golston - LED
- Mary Brainerd - IND
- Giovanni Caforio - IND
- Srikant Datar - IND
- Sherilyn McCoy - IND
- Andrew Silvernail - IND
- Lisa Skeete Tatum - IND
- Ronda Stryker - IND
- Rajeev Suri - IND